arthritis society

Canada: Patient Groups Call For Equitable Access To Medical Marijuana


By Steve Elliott
Hemp News

Canadians for Fair Access to Medical Marijuana (CFAMM), a federal nonprofit, medical cannabis patient rights organization, on Monday issued a set of recommendations to guide federal decision-makers on the needs of medical cannabis patients.

CFAMM is joined by The Arthritis Society in urging federal policymakers to take action in five key areas:
(1) eliminate sales tax;
(2) facilitate insurance coverage;
(3) allow access to all forms of cannabis;
(4) expand regulated distribution options; and
(5) promote research.

The Canadian AIDS Society has also expressed their full support of these recommendations.

Policymakers, including MPs and Senators, have been invited to a reception on the Hill to discuss the recommendations, meet patients directly affected by medical cannabis policy, and talk with key experts in the field.

In support of the recommendations, MP Nathaniel Erskine-Smith said, "Given that medical cannabis is regulated by Health Canada and used by thousands of Canadians under the supervision of a physician, it is long past time that the inequities many of these patients face be addressed."

Canada: Arthritis Society Calls For More Research On Medical Marijuana


Two thirds of Canadians currently using medical cannabis do so to ease arthritis pain

By Steve Elliott
Hemp News

In a position paper issued on Tuesday, The Arthritis Society called for more research into the efficacy and safety of medical cannabis as a therapy to alleviate symptoms of pain and fatigue caused by the chronic disease.

“More and more Canadians are accessing medical cannabis as a treatment option for severe arthritis symptoms,” explained Society president and CEO Janet Yale. “We have a duty to the people we serve to ensure that the scientific basis for the use of medical cannabis is clear and appropriate, with patient safety and improved care our foremost priorities.”

Thousands of Canadians have already received authorization from Health Canada to use medical cannabis and as many as two-thirds of those people are using the drug to help manage pain due to arthritis.

"There is much still unknown about the treatment therapy, its safety and its efficacy for coping with arthritis – leading to potential risks for patients," the Arthritis Society release claims, although if they simply asked the arthritis patients involved, they'd be talking less about risks and more about benefits.

The anecdotal evidence in support of medical cannabis for arthritis pain is very robust, and Tuesday's announcement will ensure that more clinical research will be conducted to further validate this treatment modality, according to CanniMed Ltd., the first producer to be licensed under the new Canadian Marihuana for Medical Purposes Regulations (MMPR).

Syndicate content